Federal University of Pernambuco   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Recife Brazil (1946)

Organization Overview

First Clinical Trial
2003
NCT00097110
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Hospital das Clínicas da Universidade Federal de Pernambuco | Kelly Antunes e Silva Oliveira | Maíra F Pessoa | UFPE | Universidade Federal de Pernambuco | Universidade Federal de Pernambuco/PROPESQI | Universidade Federal de Pernambuco - UFPE

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cataract (Phase 4)

Coronavirus Infections (Phase 2)

Cough (Phase 4)

Eclampsia (Phase 3)

Endophthalmitis (Phase 4)

HELLP Syndrome (Phase 3)

HIV Infections (Phase 1)

Macular Edema (Phase 2)

Obesity (Phase 4)

Pneumonia (Phase 2)

Pneumonia, Viral (Phase 2)

Postoperative Nausea and Vomiting (Phase 3)

Pre-Eclampsia (Phase 3)

Respiratory Sounds (Phase 3)

Respiratory Tract Diseases (Phase 3)

Schistosomiasis (Phase 4)

Schistosomiasis mansoni (Phase 4)

Severe Acute Respiratory Syndrome (Phase 2)

Vomiting (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 25
  • # of Trial APIs: 20